CareDx

CDNA · NASDAQ

$69.20+$2.12 (+3.16%)TodayMarket closed · Oct 20, 7:57 PM ET

Prev close $67.08

Latest news

Press releaseOct 15, 4:01 PM ETBusiness Wire
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
NewsOct 6, 11:46 AM ETChandrima Sanyal
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
NewsSep 25, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 23, 2:09 PM ETVandana Singh
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
NewsAug 3, 10:00 AM ETAvi Kapoor
CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday
Press releaseJul 31, 6:45 PM ETBusiness Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewsJul 31, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsJul 30, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsJul 30, 4:03 PM ET
CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate
Press releaseJul 30, 4:01 PM ETBusiness Wire
CareDx Announces Second Quarter 2026 Financial Results
NewsJul 16, 2:08 PM ETVandana Singh
Why Is CareDx Stock Skyrocketing Thursday?
NewsJul 16, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsJul 16, 10:11 AM ETAvi Kapoor
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
Press releaseJul 16, 8:35 AM ETBusiness Wire
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
Press releaseJul 16, 8:30 AM ETBusiness Wire
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
Press releaseJul 1, 4:05 PM ETBusiness Wire
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
NewsJun 30, 4:09 PM ET
CareDx Completes Sale Of Its Lab Products Operations To Eurobio Scientific For $171.2M
Press releaseJun 30, 4:05 PM ETBusiness Wire
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
Press releaseJun 18, 7:05 AM ETBusiness Wire
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
Press releaseJun 16, 4:05 PM ETBusiness Wire
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
Press releaseMay 20, 4:01 PM ETBusiness Wire
CareDx to Participate in Upcoming Investor Conferences
Press releaseMay 11, 4:05 PM ETBusiness Wire
CareDx Announces Dismissal of 2021 Qui Tam Suit
Press releaseMay 1, 4:01 PM ETBusiness Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewsApr 28, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseApr 28, 4:05 PM ETBusiness Wire
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
NewsApr 28, 4:02 PM ET
CareDx Q1 Adj. EPS $0.34 Beats $0.13 Estimate, Sales $117.700M Beat $104.034M Estimate
Press releaseApr 28, 4:01 PM ETBusiness Wire
CareDx Announces First Quarter 2026 Financial Results
NewsApr 28, 7:11 AM ET
Earnings Scheduled For April 28, 2026
Press releaseApr 21, 4:01 PM ETBusiness Wire
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting
Press releaseApr 20, 7:05 AM ETBusiness Wire
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
NewsApr 16, 2:37 PM ETVandana Singh
CareDx Sharpens Focus On Core Testing Services
NewsApr 16, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseApr 15, 4:30 PM ETBusiness Wire
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
Press releaseApr 14, 4:01 PM ETBusiness Wire
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
Press releaseMar 5, 4:01 PM ETBusiness Wire
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
Press releaseFeb 27, 4:01 PM ETBusiness Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseFeb 24, 5:15 PM ETBusiness Wire
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
Press releaseFeb 24, 4:01 PM ETBusiness Wire
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
NewsFeb 23, 4:02 PM ET
Uncovering Potential: CareDx's Earnings Preview
Press releaseDec 18, 5:00 PM ETBusiness Wire
CareDx Provides Notice of Proposed Derivative Settlement
Press releaseNov 4, 4:05 PM ETBusiness Wire
CareDx Announces Third Quarter 2025 Financial Results
Press releaseOct 6, 7:05 AM ETBusiness Wire
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026

Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

10 Health Care Stocks With Whale Alerts In Today’s Session

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's After-Market Session

CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate

CareDx Announces Second Quarter 2026 Financial Results

Why Is CareDx Stock Skyrocketing Thursday?

12 Health Care Stocks Moving In Thursday's Intraday Session

Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday

CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026

CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination

CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology

CareDx Completes Sale Of Its Lab Products Operations To Eurobio Scientific For $171.2M

CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology

CareDx to Participate in Upcoming Investor Conferences

CareDx Announces Dismissal of 2021 Qui Tam Suit

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 Health Care Stocks Moving In Tuesday's After-Market Session

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

CareDx Q1 Adj. EPS $0.34 Beats $0.13 Estimate, Sales $117.700M Beat $104.034M Estimate

CareDx Announces First Quarter 2026 Financial Results

Earnings Scheduled For April 28, 2026

CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing

CareDx Sharpens Focus On Core Testing Services

12 Health Care Stocks Moving In Thursday's Pre-Market Session

CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results

CareDx to Report First Quarter 2026 Financial Results on April 28, 2026

CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

CareDx Announces Fourth Quarter and Full Year 2025 Financial Results

Uncovering Potential: CareDx's Earnings Preview

CareDx Provides Notice of Proposed Derivative Settlement

CareDx Announces Third Quarter 2025 Financial Results

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting